Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic agents for reducing parathyroid hormone levels

Therapeutic agents for reducing parathyroid hormone levels

US Patent 9701712 · Granted Jul 11, 2017

Estimated economic value: $48,530,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stable liquid formulation of AMG 416 (etelcalcetide)2024
Stable liquid formulation of AMG 416 (etelcalcetide)2024
Hemiasterlin derivatives for conjugation and therapy2024
Compositions, formulations and interleukin production and purification2022
Compositions, formulations and interleukin production and purification2021
Stable liquid formulation of AMG 416 (etelcalcetide)2021
Stable liquid formulation of AMG 416 (etelcalcetide)2021
Hemiasterlin derivatives for conjugation and therapy2020
Modified amino acids comprising tetrazine functional groups, methods of preparat2019
Stable liquid formulation of AMG 416 (etelcalcetide)2019
Stable liquid formulation of AMG 416 (etelcalcetide)2019
Therapeutic agents for reducing parathyroid hormone levels2019